As part of their continued efforts towards sun safety education and awareness, La Roche-Posay is partnering with Mollie's Fund for the second year in a row. To honor the life of Mollie Biggane – a college sophomore who tragically passed away from melanoma at the age of 20 – La Roche-Posay is donating 5,000 pieces of its advanced broad spectrum UVA/UVB protection Anthelios Sunscreen Cream to Mollie's Fund. Mollie's Fund in a foundation created in memory of Mollie Biggane, a college sophomore who tragically passed away from melanoma at the age of 20. The Mollie Biggane Melanoma Foundation increases awareness for melanoma prevention, provides information and services on skin cancer detection and supports melanoma patients with education on treatment options. “We are honored to accept this donation on behalf of centers nationwide,” said Jack Biggane, Mollie's father and president of Mollie Biggane Melanoma Foundation. “La Roche-Posay has impressed us so much with its dedication to educating people about skin health and their innovative, skin-nourishing formulations, and we're excited to continue working with them for a second year. Because of their commitment to raising awareness about melanoma and the importance of early detection, there's no brand more suited to help us with the mission of our daughter's foundation than La Roche-Posay.” Entering into the fourth year of its SOS – Save Our Skin campaign, La Roche-Posay maintains its stance as a champion for sun protection and education. It is through this crusade that the company not only provides free skin checks and educates Americans about the dangers of UV rays and the importance of sun safety, but also demonstrates how to incorporate these principles into their everyday life – from routine dermatologist appointments to properly and regularly applying sunscreen each day. Mollie's Fund will distribute 5,000 pieces of Anthelios Sunscreen Cream, which offers broad spectrum UVA/UVB protection, to cancer centers across the country, with 3,600 pieces reaching infusion patients at The Moffitt Cancer Center in Tampa, FL. The remaining 1,400 units will be donated to Mollie's Fund for distribution throughout 2013.